Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
ABG-WTT Global Life Science Capital Partners GP Ltd (CIK 1832108) reported $12.3M across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: CBLL ($8.1M, 65.87%), RPID ($4.2M, 34.13%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CBLL | CERIBELL INC | $8.1M | 65.87% | 441,820 | Hold |
| 2 | RPID | RAPID MICRO BIOSYSTEMS INC | $4.2M | 34.13% | 1.8M | Hold |
Source: SEC Form 13F filings · as of 2026-03-31